Advocacy & Policy Episodes
Explore discussions on advocacy efforts, healthcare policies, and legislative changes that impact the MS community, aimed at empowering individuals living with MS.
Feb. 27, 2021
Bonus Episode: ACTRIMS 2021
Welcome to a bonus ACTRIMS Forum 2021 episode of RealTalk MS. ACTRIMS is an acronym that stands for the Americas Committee for Treatment and Research in Multiple Sclerosis and this year, the ACTRIMS Forum is a virtual meeting, bringing together over 1700 MS research scientists and clinicians to share the latest MS research news and insights. We'll take you inside the proceedings at ACTRIMS and share highlights from some of the most compelling presentations. And I'm sitting down to talk with th...
176
Jan. 11, 2021
Episode 176: The National MS Society Issues a COVID-19 Vaccine Guidance
The National MS Society has issued its initial COVID-19 vaccine guidance for people living with MS and we're covering every detail of this anxiously awaited and important announcement. We're also taking a look back with Dr. Barbara Giesser at some of the things that made life better for people living with MS in 2020. We have a lot to talk about! Are you ready for RealTalk MS??! National MS Society releases COVID-19 vaccine guidance for people living with MS 1:44 Some of the things that made li...
175
Jan. 4, 2021
Episode 175: People-Powered MS Research with the CEO of iConquerMS Sara Loud
Research creates the future for people affected by MS. And clinical research can't happen without your participation. Joining me as my guest is Sara Loud, the CEO of iConquerMS, the people-powered-research network that puts you at the center of MS research. We're also celebrating a whole list of MS advocacy wins that will translate into making life better for people living with MS in the United States. We'll tell you about a study that clearly demonstrates why it's essential to start disease-m...
171
Dec. 7, 2020
Episode 171: The Country with One of the Highest Rates of MS in the World with Dr. Pamela Valentine
Every day, 12 more Canadians are diagnosed with multiple sclerosis. Facing one of the highest MS rates in the world, spread across a geographically large country, the MS Society of Canada is the only national voluntary organization in Canada that supports cutting-edge MS research while providing services and support to more than 90,000 people living with MS. Joining me as my guest is Dr. Pamela Valentine, who is not only the president & CEO of the MS Society of Canada but also a multi-award win...
157
Aug. 31, 2020
Episode 157: The Future of Telehealth with Mei Wa Kwong
One of the very few bright spots to emerge during the COVID-19 pandemic is the overall effectiveness and efficiency of telemedicine. And although people living with MS and their doctors have largely hailed telemedicine as a success, there are significant obstacles to overcome before it can become a permanent part of our healthcare system. My guest is Mei Wa Kwong, the Executive Director of the Center for Connected Health Policy, and we're talking about the things that need to happen to ensure t...
153
Aug. 3, 2020
Episode 153: Improving Your Health Literacy with Dr. Kalina Sanders and Managing MS with Wellness Coach Kate Costello
MS patients experience better treatment outcomes when they actively participate in their own care. And that requires high health literacy. One of my guests is health literacy expert Dr. Kalina Sanders and we're talking about how being an informed patient can have a significant impact on the healthcare you receive. A well-rounded MS treatment plan will include wellness practices like making smart food choices and adding exercise to your routine. But making changes to our health behaviors is chal...
150
July 13, 2020
Episode 150: The Cost of MS Medications, Drug Development, and More: My Conversation with Genentech CEO Alexander Hardy
Conversations about MS almost always get around to the high cost of MS disease-modifying therapies. Joining me on the podcast is the CEO of Genentech, Alexander Hardy. Genentech is a biotech company that many of you know as the manufacturer of Ocrevus, the first approved disease-modifying therapy that treats both relapsing-remitting MS and primary progressive MS. During our wide-ranging conversation, Alexander and I get into the cost of MS prescription medications, the real costs of bringing a ...
147
June 22, 2020
Episode 147: Racial Disparities in MS Care with Dr. Jackie Bhattarai
Over the past several weeks, the United States has been forced to re-visit, re-examine, and reconsider its own history of racial inequality. This difficult but necessary national conversation has been driven by instances of racial injustice that have their origins in much broader systemic or institutional racism. Our conversations on RealTalk MS typically focus on multiple sclerosis research and multiple sclerosis care. So how does the subject of racial inequality find its way onto today's episo...
138
April 20, 2020
Episode 138: COVID-19 & MS In Minority Populations with Dr. Mitzi Joi Williams
This week, and for the foreseeable future, we're committed to sharing the most updated and reliable information on COVID-19 and MS. Returning as my guest on the podcast is Dr. Mitzi Joi Williams. Dr. Williams is a Board-Certified Neurologist and Fellowship trained Multiple Sclerosis Specialist who is passionate about educating and empowering people affected by MS to understand the disease process and the goals of treatment. She is a sought-after consultant, speaker, researcher, and author with ...
March 11, 2020
Bonus Episode: MS Awareness Week with Damian Washington and Dan & Jen Digmann
Welcome to this MS Awareness Week bonus episode of RealTalk MS. In this special episode, I'm talking with Damian Washington. Damian is an actor and a prolific vlogger. He was diagnosed with MS in 2016, and when you watch one of Damian's videos, it's impossible not to be hooked by his infectious personality. I'm also talking with Dan and Jennifer Digmann. Jennifer was diagnosed with progressive MS in 1997, and Jennifer's husband Dan was diagnosed with relapsing-remitting MS in 2000. Dan & Jennif...